Low-density lipoprotein cholesterol lowering with evoloumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects with Elevated Risk) - Bonaca, M P; Nault, P; Giugliano, R P (Circulation, 2018)
et al.